Eli Lilly says will keep animal health business, Reuters reports


Eli Lilly (LLY) has no plans to spin off or sell its Elanco animal health business, CEO John Lechleiter says, Reuters reports. Pfizer (PFE) spun off its animal health business earlier this month through an IPO that raised $2.2B.


View Comments (0)